Heterobivalent fibroblast activation protein-targeted Radiotheranostic ligands integrating cyclic peptide and small-molecule motifs for enhanced tumor retention.
Fibroblast activation protein (FAP), which is highly expressed in cancer-associated fibroblasts, has emerged as an attractive target for tumor imaging and radionuclide therapy. However, FAP-targeted radioligands suffer from rapid tumor washout, limiting effective dose delivery. The heterobivalent design strategy effect...